StockpollyBeta
Get App
Popularity #2,502
EOLS · NASDAQ · Drug Manufacturers - Specialty & Generic

Evolus (EOLS)

Sells a cosmetic-only neurotoxin and hyaluronic-acid filler line directly to physicians on a cash-pay basis.

$8.25
After hours+0.01 (+0.06%)
At close$8.25(+3.19%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue506159676179696969907384
Cost of revenue152219201829222423312627
Gross profit353941474350474546594757
484749555853625657605462
Research & development272222222322
434345505350575753555257
Selling & marketing070009000000
General & administrative03600042000000
Other expenses3−222403−32103
Operating income−13−9−9−8−15−2−15−10−120−7−5
−3−3−4−4−4−4−4−7−41−4−4
Interest income001111100000
Interest expense445555474444
Other non-operating income0−4−1−1−1−2−100−50−1
Income before tax−17−12−13−11−19−6−19−17−161−10−8
Income tax expense000000000000
Net income from continuing operations−17−12−13−11−19−7−19−17−160−11−8
Net income−17−12−13−11−19−7−19−17−160−11−8
EPS, basic−$0.30−$0.21−$0.22−$0.18−$0.30−$0.11−$0.30−$0.27−$0.24$0.00−$0.16−$0.12
EPS, diluted−$0.30−$0.21−$0.22−$0.18−$0.30−$0.11−$0.30−$0.27−$0.24$0.00−$0.16−$0.12
Weighted average shares, basic575759636362646565646566
Weighted average shares, diluted575759636363646565646566
EBITDA−12−4−7−5−131−13−8−107−4−4
Depreciation & amortization112211222330
EBIT−13−5−8−7−14−1−14−10−114−6−4